Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 23.70M $3.15B Dec. 31, 2013
FMR 20.68M $3.15B March 31, 2014
T. Rowe Price Associates 15.47M $2.35B March 31, 2014
Vanguard 9.90M $1.51B March 31, 2014
Jennison Associates 8.47M $1.29B March 31, 2014
STATE STREET CORPORATION 7.81M $1.19B March 31, 2014
JPMORGAN CHASE & CO 7.36M $1.12B March 31, 2014
Wells Fargo & Company 6.03M $917.03M March 31, 2014
Sands Capital Management 5.27M $801.48M March 31, 2014
BlackRock Institutional Trust Company, N.A. 5.25M $798.78M March 31, 2014
BlackRock Fund Advisors 4.84M $735.60M March 31, 2014
Inves 4.15M $631.87M March 31, 2014
Columbia Wanger Asset Management 3.71M $344.78M March 31, 2012
WINSLOW CAPITAL MANAGEMENT INC /MN 2.83M $430.43M March 31, 2014
NORTHERN TRUST 2.75M $419.07M March 31, 2014
Ameriprise Financial 2.45M $372.93M March 31, 2014
Artisan Partners Limited Partnership 2.32M $352.40M March 31, 2014
American Century Companies 2.02M $268.55M Dec. 31, 2013
Janus Capital Management 1.87M $172.62M June 30, 2013
BlackRock 1.84M $280.68M March 31, 2014
VIKING GLOBAL INVESTORS 1.84M $279.41M March 31, 2014

Who sold Alexion Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
TIAA-CREF Investment Management Sept. 30, 2011 2.18M $139.64M